Laura E. Niklason - 29 Aug 2024 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Role
President, CEO and Director, Director
Signature
/s/ Laura E. Niklason by Dale A. Sander as Attorney-in-Fact
Issuer symbol
HUMA
Transactions as of
29 Aug 2024
Net transactions value
+$7,998
Form type
4
Filing time
03 Sep 2024, 16:23:53 UTC
Previous filing
29 Aug 2024
Next filing
11 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HUMA Common Stock Purchase $7,998 +1,222 +0.51% $6.54 242,054 29 Aug 2024 Direct F1
holding HUMA Common Stock 1,148,240 29 Aug 2024 By The Niklason Living Trust
holding HUMA Common Stock 510,161 29 Aug 2024 By spouse
holding HUMA Common Stock 3,677,262 29 Aug 2024 By Ayabudge LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This purchase is matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, against a portion of the sale by Ayabudge LLC, an entity controlled by the Reporting Person's spouse, of 809,786 shares of the Issuer's common stock on May 31, 2024. The Reporting Person has paid the Issuer $3,391.05, representing the full amount of profit realized in connection with this purchase.